Please login to the form below

Not currently logged in

Pfizer's Elvira Sanz named next president of Farmaindustria

Will lead Spanish pharma industry body for the new two years

Pfizer Spain Farmaindustria Elvira SanzSpanish pharmaceutical industry body Farmaindustria has selected Pfizer Spain's president and CEO Elvira Sanz to serve as its new president.

She will serve a two-year term and replaces Ferrer Grupo CEO Jordi Rementol, who took office in 2010.

Sanz has worked in the pharmaceutical industry for nearly 25 years, holding increasingly senior roles at Abelló, MSD, Roche and Cyanamid.

She became directorate general at Wyeth Spain in 2000 and was named president and CEO of Pfizer Spain in 2009.

Sanz takes up her new role at Farmaindustria at a time of increasing difficulties for the Spanish pharma industry, which has been hit hard by a series of government cost-containment measures and unpaid bills.

26th October 2012

From: Research, Sales, Marketing, Regulatory



Featured jobs

Subscribe to our email news alerts


Add my company
Merrill Brink International

Merrill Brink International is a leading provider of life sciences, legal, financial, manufacturing and corporate language solutions for global companies....

Latest intelligence

White paper download: Creating experiences to improve patient outcomes
Download our white paper "Creating experiences to improve patient outcomes" to learn the steps to building an effective customer experience strategy....
Organisational Memory
In a knowledge-based industry with high labour mobility, retaining that knowledge within an organisation during a drug’s lifecycle can be tricky. If we undervalue the knowledge, experience and marketing understanding...
Thoughts on the intersection between technology and psychology
Paul Mannu - Master Practitioner, Behavioural Insights at Cello Health Insight gives us his succinct thoughts on the intersection between technology and psychology...